JP2022517399A5 - - Google Patents

Info

Publication number
JP2022517399A5
JP2022517399A5 JP2021541187A JP2021541187A JP2022517399A5 JP 2022517399 A5 JP2022517399 A5 JP 2022517399A5 JP 2021541187 A JP2021541187 A JP 2021541187A JP 2021541187 A JP2021541187 A JP 2021541187A JP 2022517399 A5 JP2022517399 A5 JP 2022517399A5
Authority
JP
Japan
Prior art keywords
referred
sequence
sar
peptide ligand
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021541187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022517399A (ja
Filing date
Publication date
Priority claimed from GBGB1900530.5A external-priority patent/GB201900530D0/en
Application filed filed Critical
Publication of JP2022517399A publication Critical patent/JP2022517399A/ja
Publication of JP2022517399A5 publication Critical patent/JP2022517399A5/ja
Pending legal-status Critical Current

Links

JP2021541187A 2019-01-15 2020-01-15 Ｃｄ３８に特異的な二環式ペプチドリガンド Pending JP2022517399A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1900530.5 2019-01-15
GBGB1900530.5A GB201900530D0 (en) 2019-01-15 2019-01-15 Bicyclic peptide ligands specific for CD38
PCT/GB2020/050074 WO2020148530A1 (en) 2019-01-15 2020-01-15 Bicyclic peptide ligands specific for cd38

Publications (2)

Publication Number Publication Date
JP2022517399A JP2022517399A (ja) 2022-03-08
JP2022517399A5 true JP2022517399A5 (OSRAM) 2023-01-25

Family

ID=65528178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021541187A Pending JP2022517399A (ja) 2019-01-15 2020-01-15 Ｃｄ３８に特異的な二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20220133733A1 (OSRAM)
EP (1) EP3911366A1 (OSRAM)
JP (1) JP2022517399A (OSRAM)
CN (1) CN113597317A (OSRAM)
GB (1) GB201900530D0 (OSRAM)
WO (1) WO2020148530A1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102754019B1 (ko) 2014-10-29 2025-01-14 바이시클러드 리미티드 Mt1-mmp에 특이적인 바이사이클릭 펩타이드 리간드
CN111032678A (zh) 2017-06-26 2020-04-17 拜西克尔德有限公司 具有可检测部分的双环肽配体和其用途
ES2926195T3 (es) 2017-08-04 2022-10-24 Bicycletx Ltd Ligandos peptídicos bicíclicos específicos de CD137
AU2019224659A1 (en) 2018-02-23 2020-10-15 Bicycletx Limited Multimeric bicyclic peptide ligands
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
CN113474045A (zh) 2018-12-21 2021-10-01 拜斯科技术开发有限公司 Pd-l1特异性的双环肽配体
US12551567B2 (en) 2018-12-21 2026-02-17 Bicyclerd Limited Bicyclic peptide ligands specific for PD-L1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
CA3189761A1 (en) 2020-08-03 2022-02-10 Gemma Mudd Peptide-based linkers
GB202016331D0 (en) * 2020-10-15 2020-12-02 Bicyclerd Ltd Bicyclic peptide ligand drug conjugates
CN118388598A (zh) * 2024-04-22 2024-07-26 苏州大学附属第一医院 标记前体、探针及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1569956B1 (en) * 2002-12-12 2014-02-26 Tel Aviv University Future Technology Development L.P. Glycogen synthase kinase-3 inhibitors
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
ES2541436T3 (es) 2004-02-06 2015-07-20 Morphosys Ag Anticuerpos humanos anti-CD38 y usos para ellos
PT1844337E (pt) 2005-01-24 2014-04-03 Pepscan Systems Bv Compostos ligantes, compostos imunogénicos e peptidomiméticos
EP3312196B1 (en) * 2005-03-23 2019-07-17 Genmab A/S Antibodies against cd38 for treatment of multiple myeloma
WO2009098450A2 (en) 2008-02-05 2009-08-13 Medical Research Council Methods and compositions
HUE045872T2 (hu) * 2014-05-21 2020-01-28 Entrada Therapeutics Inc Sejteket penetráló peptidek és ezek elõállítására és alkalmazására szolgáló eljárások
KR102754019B1 (ko) 2014-10-29 2025-01-14 바이시클러드 리미티드 Mt1-mmp에 특이적인 바이사이클릭 펩타이드 리간드
CN107810190A (zh) * 2015-04-28 2018-03-16 洛桑联邦政府综合工科学校（Epfl) 酶活化因子XII (FXIIa)的新型抑制剂
CN111032678A (zh) * 2017-06-26 2020-04-17 拜西克尔德有限公司 具有可检测部分的双环肽配体和其用途
GB201810320D0 (en) * 2018-06-22 2018-08-08 Bicycletx Ltd Peptide ligands for binding to CD38

Similar Documents

Publication Publication Date Title
JP2022517442A5 (OSRAM)
JP2022518695A5 (OSRAM)
JP2022513806A5 (OSRAM)
JP2022517040A5 (OSRAM)
JP2022517698A5 (OSRAM)
JP2022513223A5 (OSRAM)
JP2022514687A5 (OSRAM)
JP2022512478A5 (OSRAM)
JP2022514255A5 (OSRAM)
JP2022544058A5 (OSRAM)
JP2022518210A5 (OSRAM)
JP2022515720A5 (OSRAM)
JP2022546878A5 (OSRAM)
JP2022552839A5 (OSRAM)
US10335455B2 (en) Method for prevention or treatment of intractable inflammatory bowel disease
JP2021100937A5 (OSRAM)
JP2025163134A5 (OSRAM)
RU2004110726A (ru) Применение оксинтомодулина, способ и фармацевтическая композиция для профилактики или лечения избыточной массы тела, способ снижения массы тела
JP2005511503A5 (ja) 過剰体重を防止または治療するためのオキシントモジュリン
FI3746467T3 (fi) Muutetut lipidoidut relaksiinin b-ketjun peptidit ja niiden terapeuttinen käyttö
CH683499A5 (it) Composizioni farmaceutiche contenenti N-(acil)-cisteina per il trattamento di malattie indotte da infezioni di HIV e loro procedimento di preparazione.
JP2022506716A5 (OSRAM)
JP2023549229A5 (OSRAM)
WO2008016890A1 (en) Antitumorigenic drug combination
JP2023504904A5 (OSRAM)